Nice | Lubiprostone for treating chronic idiopathic constipation

5th August 2014 by Louise Hudman

Nice | Lubiprostone for treating chronic idiopathic constipation

This is guideline from NICE on a newly recommended treatment for chronic idiopathic constipation.

The medication is Lubiprostone, which works by activating chloride channels in the GI tract, thus increasing intestinal secretions and improving constipation.

It has a different method of action to prucalopride, which NICE released guidance on in 2011. Lubiprostone is more cost-effective than prucalopride.

Join

Join to view the rest of this content, as well as access all the benefits of joining NASGP.

Join

Login

Already a member? Login to view this content.

Login

"The quality and contents of the magazine are superb. It's wonderful that GP locums now have a voice and are seen as a vital part of the medical workforce."

Dr Irene Bainbridge

See the full list of features within our NASGP membership plans

Membership